A Fast-Moving Inherited Macular Dystrophy
A dam wall that quietly thickens and stiffens in the wrong way eventually forces engineers to cut emergency spillways through it, channels that are rushed, poorly reinforced, and prone to giving way. Something similar happens behind the retina in Sorsby fundus dystrophy: a faulty protein causes Bruch's membrane to thicken abnormally, and the retina responds by forcing new blood vessels through that weakened barrier — vessels that are structurally poor from the outset and prone to leaking almost as soon as they form. It's this early, abnormal vessel growth — turning up decades sooner than it would in typical age-related disease — that earns Sorsby dystrophy its reputation as one of the more aggressive conditions on this site.
For a Tanzanian patient whose central vision collapses over a matter of weeks instead of years, usually somewhere in their thirties or forties, that sheer pace is frequently the first hint pointing toward Sorsby rather than a gentler, more typical dystrophy.
Speed is really the signature of this condition — one eye can lose meaningful central vision within a matter of weeks, and the second eye tends to follow suit within a handful of years afterward. People often describe straight edges suddenly appearing bent, or a blur spreading rapidly across the middle of their vision, and a fair number recall a strange difficulty with dim light that showed up quietly, months before anything more obvious.
TIMP3 is the gene at fault, and its ordinary role is to keep tissue turnover around Bruch's membrane properly balanced. When that role isn't fulfilled, the membrane grows abnormally thick, and the retina's answer is to push a network of new vessels through the compromised barrier — vessels that are weak from the start and begin leaking almost right away. A single copy of the faulty gene, inherited from either parent, is enough to trigger the whole process.
A scattering of pale yellow-white deposits along the retinal vessels is frequently the first clue an examiner picks up during a standard fundus check. From that point, imaging turns toward confirming whether new vessels are actively present and leaking — OCT angiography usually does the job, with fluorescein angiography brought in when a more detailed picture is needed. A TIMP3 genetic test confirms what's behind it all, and given how fast this condition can move, we treat that test as urgent rather than routine.
If active leaking vessels turn up, dealing with them takes priority over everything else in the plan. Once the eye has been brought under control and stabilised, patients who qualify move into regenerative stem cell therapy aimed at supporting the retina going forward, and given how quickly Sorsby can shift, we schedule these patients for review more frequently than we would with a slower dystrophy.
It is, and that unusual speed is actually one of the clues that points us toward Sorsby dystrophy specifically. Almost every other inherited macular condition unfolds over years rather than weeks, which is what makes this pace stand out.
That mix-up does happen, since both conditions can produce new leaking vessels that look alike on imaging. What separates them is the age it started, whether it runs in the family, and confirmation through a TIMP3 genetic test.
It's certainly something we act on quickly, since untreated leaking vessels can cause further vision loss in a short space of time. Bringing that specific issue under control is always the first priority.
Not definitely — but the odds are worth taking seriously, since this is a dominant condition and each child of an affected parent has roughly a fifty percent chance of carrying the gene. The severity can differ quite a bit from person to person, and genetic testing can give your family a clearer answer.